Kaynes is a diversified EMS company — automotive, industrial, aerospace, medical, railways — that has built a genuine semiconductor packaging asset in Kaynes Semicon, whose Sanand, Gujarat OSAT facility began commercial production of Intelligent Power Modules in early 2026 and was formally inaugurated by the Prime Minister in April 2026, described in press coverage as India's second operational chip (OSAT) unit under the India Semiconductor Mission. The company has also allocated 60-70% of new PCB production capacity to High-Density Interconnect boards used in AI servers and high-speed networking, though this is a manufacturing-capability move rather than a disclosed AI-server end-product line — this report's research found no confirmed Nvidia/AMD/Intel partner status and no confirmed IndiaAI Mission or C-DAC contract for Kaynes, a genuine point of contrast with Netweb.
The past twelve months have been materially difficult. On 5 December 2025, Kotak Institutional Equities flagged related-party-disclosure inconsistencies across Kaynes Technology, its subsidiary Kaynes Electronics Manufacturing, and group entity Iskraemeco, raising questions under three separate accounting standards; the stock fell more than 12% intraday, and the company subsequently characterised the inconsistencies as an inadvertent standalone-statement omission, since rectified. CRISIL placed the company on "A/Watch Developing" that same month before removing the watch and reaffirming CRISIL A/Stable in March 2026. Separately, and independently of that episode, SEBI issued a formal settlement order on 27 March 2026 against promoter and Executive Vice Chairman Ramesh Kunhikannan, who paid ₹23.42 lakh to settle an insider-trading/unpublished-price-sensitive-information database investigation covering a March-June 2023 trading window.
FY26 results then confirmed the operational side of the deterioration: revenue of ₹3,626 crore came in roughly 19-20% below the company's own original ₹4,500 crore guidance (twice cut during the year), and operating cash flow was negative ~₹600 crore, against a working-capital cycle that had stretched to 179 days by year-end. The stock fell from an October 2025 high of ₹7,705 to the ₹3,500 range by this report's research date — a decline of roughly 54%.
Net: a SELL. Kaynes holds a real, operating semiconductor asset that matters to India's AI-compute- stack build-out at the national level, but the combination of a confirmed SEBI settlement against its top promoter, a disclosure-inconsistency controversy, and a substantial guidance miss with negative cash flow means this report cannot separate the OSAT-asset story from a genuine, recent deterioration in execution and governance quality.
Kaynes is a mainboard NSE/BSE-listed company subject to the full SEBI LODR regime. Chairperson (Savitha Ramesh) and Managing Director (Dr Muthukumar Narayanaswamy) are distinct individuals, so the board does not carry a combined-Chairman-and-MD structure; however, promoter and Executive Vice Chairman Ramesh Kunhikannan (Savitha Ramesh's husband) remains a central, non-titular figure in the company's governance — a family-linked board structure worth naming explicitly rather than glossing over. This report's research could not confirm the current total board size or independent-director percentage.
The company issued prompt, same-day clarifications on both the December 2025 related-party-disclosure controversy and a separate media report about a possible auditor change (which it denied), rather than allowing either story to sit unaddressed. Two new independent, non-executive directors — Rajesh Balkrishna Mittal and Annadurai Mylswamy — were appointed in May 2026, broadening board composition following the governance controversies of the prior months. The statutory auditor, K.P. Rao & Co, issued an unmodified audit opinion on the FY26 results.
The husband-and-wife Chairperson/Executive-Vice-Chairman structure, while not itself a LODR violation, concentrates influence within one family group at the top of the company. The company's own explanation for the December 2025 related-party-disclosure gap — an "inadvertent" standalone-statement omission — is Kaynes's own characterisation, not independently verified by this research; Kotak's original note raised questions specific enough (mismatched payables/receivables figures, capitalisation-of-intangibles questions) that a reader should treat the "inadvertent and rectified" framing as the company's position, not a settled external finding.
Yes — a confirmed, primary-sourced SEBI settlement order. SEBI's own website confirms a settlement order dated 27 March 2026 against Ramesh Kunhikannan (described in contemporaneous coverage as "MD of Kaynes Technology India" at the relevant 2023 period) for lapses in maintaining a Structured Digital Database of unpublished price-sensitive information, paying ₹23.42 lakh, with the order subject to reopening in case of misrepresentation or breach of settlement terms. This is the clearest, most directly-attributable governance red flag identified for any company in this report, and should be weighted accordingly by any reader.
Any further SEBI or exchange action connected to the December 2025 related-party-disclosure episode; confirmation of the current, complete board composition and independent-director percentage; and whether FY27 results show the order-book-to-revenue conversion gap narrowing.
Materially weaker than every other company in this report, on primary-sourced evidence, not inference. A confirmed SEBI settlement against the company's top promoter, a disclosure-inconsistency episode serious enough to trigger a CRISIL rating-watch placement, and a family-concentrated board structure together justify a real governance discount — reflected here in a target-multiple band set well below the current trailing multiple, on top of, not instead of, the operational concerns in the valuation section below.
FY26 PAT of ₹364cr on an implied share count of ~6.721cr (market cap ÷ CMP) gives FY26 EPS of ~₹54.2. Applying an indicative 20% forward-growth assumption (well below the company's historical growth rate, reflecting the FY26 execution miss and reduced management credibility on guidance) gives a constructed FY27E EPS of ~₹65.0. We apply a target multiple band well below the current trailing multiple, reflecting the confirmed governance and execution deterioration described above:
| Scenario | Target P/E (FY27E) | FY27E EPS (~) | Target price | Upside/(downside) |
|---|---|---|---|---|
| Bear | 35.0x | 65.0 | 2,275 | (35.3)% |
| Base | 45.0x | 65.0 | 2,925 | (16.8)% |
| Bull | 55.0x | 65.0 | 3,575 | +1.7% |
Base case rounded to ₹2,925. Named brokerage targets found in this research (JM Financial ₹4,350, CLSA ₹4,200, Elara Capital ₹5,365) are all materially above our base case; we set ours more conservatively given the confirmed SEBI settlement, the December 2025 disclosure controversy, and the negative operating cash flow, none of which this report found fully reflected in those named targets' public rationale.
Upgrade triggers: two consecutive quarters of order-book-to-revenue conversion meeting stated guidance; operating cash flow turning positive; no further regulatory action connected to the December 2025 episode. Downgrade triggers: any further SEBI or exchange action; a third consecutive guidance miss; or deterioration in the working-capital cycle beyond 179 days.
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 1,805 | 2,722 | 3,626 |
| EBITDA margin | 14% | 15% | 16% |
| Net profit (PAT) | 183 | 293 | 364 |
| Selected metrics | FY26 |
|---|---|
| ROE | 8.69% |
| ROCE | 12.7% |
| Operating cash flow | ~(₹600) cr |
| Working-capital cycle | 179 days |
Source: screener.in (18 Sep 2026), cross-checked against JM Financial's 14 May 2026 downgrade note as reported by BusinessToday.
Dart Consultants is a market intelligence and technology service provider, not a SEBI-registered Investment Adviser or Research Analyst. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The SELL rating above is an educational device for summarising public information, not a regulated recommendation. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, Kaynes Technology India Limited, and have received no compensation from the company. Readers should treat this stock as carrying above-average governance and execution risk, independent of this report's rating, given the confirmed SEBI settlement order and FY26 guidance miss described above.
| 12-month target | ₹2,925 |
| CMP (18 Sep 2026) | ₹3,515 |
| Implied upside | (16.8)% |
| Rating | SELL |
| Market cap | ₹23,629 cr |
| P/E (trailing) | ~68.0x |
| Book value/share | ₹708 |
| ROE / ROCE | 8.69% / 12.7% |
| Credit rating | CRISIL A/Stable (post-Watch) |
| Promoters | 53.46% |
| Public | 28.93% |
| DII | 11.78% |
| FII | 5.82% |
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 1,805 | 2,722 | 3,626 |
| EBITDA margin | 14% | 15% | 16% |
| PAT | 183 | 293 | 364 |